| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |